Identification of Genome-Wide Mutations in Ciprofloxacin-Resistant F. tularensis LVS Using Whole Genome Tiling Arrays and Next Generation Sequencing.
Francisella tularensis is classified as a Class A bioterrorism agent by the U.S. government due to its high virulence and the ease with which it can be spread as an aerosol. It is a facultative intracellular pathogen and the causative agent of tularemia. Ciprofloxacin (Cipro) is a broad spectrum antibiotic effective against Gram-positive and Gram-negative bacteria. Increased Cipro resistance in pathogenic microbes is of serious concern when considering options for medical treatment of bacterial infections. Identification of genes and loci that are associated with Ciprofloxacin resistance will help advance the understanding of resistance mechanisms and may, in the future, provide better treatment options for patients. It may also provide information for development of assays that can rapidly identify Cipro-resistant isolates of this pathogen. In this study, we selected a large number of F. tularensis live vaccine strain (LVS) isolates that survived in progressively higher Ciprofloxacin concentrations, screened the isolates using a whole genome F. tularensis LVS tiling microarray and Illumina sequencing, and identified both known and novel mutations associated with resistance. Genes containing mutations encode DNA gyrase subunit A, a hypothetical protein, an asparagine synthase, a sugar transamine/perosamine synthetase and others. Structural modeling performed on these proteins provides insights into the potential function of these proteins and how they might contribute to Cipro resistance mechanisms.
Physical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 94550, United States of America.
Crystal J
CJ
Jaing
Computations Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 94550, United States of America.
Kevin S
KS
McLoughlin
Physical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 94550, United States of America.
James B
JB
Thissen
Computations Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 94550, United States of America.
Adam
A
Zemla
Computations Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 94550, United States of America.
Shea N
SN
Gardner
Physical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 94550, United States of America.
Lisa M
LM
Vergez
Physical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 94550, United States of America.
Feliza
F
Bourguet
Physical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 94550, United States of America.
Shalini
S
Mabery
Eureka Genomics, Hercules, CA, 94547, United States of America.
Viacheslav Y
VY
Fofanov
Eureka Genomics, Hercules, CA, 94547, United States of America.
Heather
H
Koshinsky
Physical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 94550, United States of America.
Paul J
PJ
Jackson
Nucleic Acids Res. 2013 Nov;41(21):9911-23
23965305
Antimicrob Agents Chemother. 1996 Apr;40(4):870-3
8849242
J Antimicrob Chemother. 2014 Jan;69(1):101-10
23963236
Biochemistry. 2010 Aug 24;49(33):7227-37
20604544
Antimicrob Agents Chemother. 1995 Nov;39(11):2478-83
8585729
Mol Gen Genet. 1988 Jan;211(1):1-7
2830458
BMC Bioinformatics. 2011 Jun 02;12:226
21635786
Science. 2006 Mar 31;311(5769):1932-6
16527929
Bioinformatics. 2009 Sep 15;25(18):2438-9
19602525
Antimicrob Agents Chemother. 2006 Sep;50(9):2971-5
16940090
PLoS One. 2008 May 14;3(5):e2163
18478124
J Microbiol Methods. 2010 Jan;80(1):106-8
19879904
Antimicrob Agents Chemother. 2010 Jul;54(7):2787-92
20385868
Biochemistry. 2016 Aug 16;55(32):4485-94
27275764
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W577-81
15980540
Science. 2009 Dec 4;326(5958):1415-8
19965760
Int J Antimicrob Agents. 2008 Sep;32(3):207-20
18619818
Mol Cell Probes. 2003 Feb;17(1):41-7
12628593
J Bacteriol. 1995 Jul;177(14):3904-10
7608059
Infect Immun. 2006 Mar;74(3):1949-53
16495572
J Antimicrob Chemother. 2000 Aug;46(2):287-90
10933655
Antimicrob Agents Chemother. 2000 Oct;44(10):2709-14
10991849
Appl Environ Microbiol. 2009 Oct;75(20):6496-503
19700544
Nucleic Acids Res. 2003 Jul 1;31(13):3370-4
12824330
Antimicrob Agents Chemother. 2003 Jul;47(7):2362-5
12821500
Methods Mol Biol. 2000;132:365-86
10547847
Biochemistry. 2007 Aug 7;46(31):8999-9006
17630700
Genome Res. 2008 May;18(5):742-50
18407970
Biochemistry. 2008 Mar 4;47(9):2833-40
18247575
Microbiology. 2006 Nov;152(Pt 11):3425-35
17074911
J Hyg Epidemiol Microbiol Immunol. 1980;24(1):84-91
7190590
Drug Resist Updat. 1999 Feb;2(1):38-55
11504468
Indian J Pathol Microbiol. 2000 Jan;43(1):51-3
12583420
Antimicrob Agents Chemother. 2011 May;55(5):1946-52
21357297
J Antimicrob Chemother. 1987 Nov;20(5):645-56
3501421
Infect Immun. 2005 Dec;73(12):8345-52
16299332
Mol Cell Probes. 2010 Jun;24(3):154-60
20100564
Antimicrob Agents Chemother. 2005 Jul;49(7):2954-8
15980374
Infect Immun. 2006 Dec;74(12):6895-906
17000723
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W111-5
15980437